PARA vs. PFE
Compare and contrast key facts about Paramount Global Class B (PARA) and Pfizer Inc. (PFE).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: PARA or PFE.
Correlation
The correlation between PARA and PFE is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
PARA vs. PFE - Performance Comparison
Key characteristics
PARA:
-0.26
PFE:
0.01
PARA:
-0.05
PFE:
0.19
PARA:
0.99
PFE:
1.02
PARA:
-0.14
PFE:
0.00
PARA:
-0.66
PFE:
0.02
PARA:
19.32%
PFE:
9.55%
PARA:
49.31%
PFE:
23.19%
PARA:
-90.06%
PFE:
-54.82%
PARA:
-87.55%
PFE:
-51.42%
Fundamentals
PARA:
$8.03B
PFE:
$144.85B
PARA:
-$9.06
PFE:
$1.41
PARA:
0.29
PFE:
0.18
PARA:
$21.23B
PFE:
$63.63B
PARA:
$6.27B
PFE:
$41.72B
PARA:
-$5.12B
PFE:
$16.34B
Returns By Period
In the year-to-date period, PARA achieves a 8.13% return, which is significantly higher than PFE's -2.06% return. Over the past 10 years, PARA has underperformed PFE with an annualized return of -13.54%, while PFE has yielded a comparatively higher 1.56% annualized return.
PARA
8.13%
10.13%
4.34%
-4.00%
-14.99%
-13.54%
PFE
-2.06%
-1.21%
-8.70%
-1.66%
-1.27%
1.56%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
PARA vs. PFE — Risk-Adjusted Performance Rank
PARA
PFE
PARA vs. PFE - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Paramount Global Class B (PARA) and Pfizer Inc. (PFE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
PARA vs. PFE - Dividend Comparison
PARA's dividend yield for the trailing twelve months is around 1.77%, less than PFE's 6.61% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
PARA Paramount Global Class B | 1.77% | 1.91% | 2.64% | 5.69% | 3.18% | 2.58% | 1.86% | 1.65% | 1.22% | 1.04% | 1.27% | 0.98% |
PFE Pfizer Inc. | 6.61% | 6.33% | 5.70% | 3.12% | 2.64% | 3.92% | 3.68% | 3.12% | 3.54% | 3.70% | 3.48% | 3.34% |
Drawdowns
PARA vs. PFE - Drawdown Comparison
The maximum PARA drawdown since its inception was -90.06%, which is greater than PFE's maximum drawdown of -54.82%. Use the drawdown chart below to compare losses from any high point for PARA and PFE. For additional features, visit the drawdowns tool.
Volatility
PARA vs. PFE - Volatility Comparison
Paramount Global Class B (PARA) has a higher volatility of 7.28% compared to Pfizer Inc. (PFE) at 6.38%. This indicates that PARA's price experiences larger fluctuations and is considered to be riskier than PFE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
PARA vs. PFE - Financials Comparison
This section allows you to compare key financial metrics between Paramount Global Class B and Pfizer Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities